Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multifaceted analysis of hypoalbuminemia during zolbetuximab plus chemotherapy
jRCT1031250843Recruiting
- Sponsor
- Astellas Pharma
- Start
- Mar 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of zolbetuximab in gastric cancer (GC) and esophagogastric junction cancer, sponsored by Astellas Pharma. Started Mar 2026; status: recruiting.
02
Drugs
zolbetuximab
03
Conditions
gastric cancer (GC)esophagogastric junction cancer
Beyond the preview
Go deeper on jRCT1031250843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250843.